GGrantIndex
Sort

15,842 grants matching pancreatic cancer

Program the Immune System against RAS-driven Cancer

$217,992
Xiaojing J Gao · Stanford University · R61 · FY2023 · CA

MCM Helicase as a Novel Target for Pancreatic Cancer Treatment

$217,935
Mark G. Alexandrow · H. Lee Moffitt Cancer Ctr & Res Inst · R21 · FY2011 · CA

RECEPTORS FOR CCK AND OTHER GI HORMONES

$217,919
University Of Michigan At Ann Arbor · R01 · FY2000 · DK

Tissue and Pathology Resources

$217,880
Massimo F Loda · Dana-Farber Cancer Inst · P50 · FY2010 · CA

KRas Ligand Development

$217,826
Craig M Crews · Yale University · R21 · FY2016 · CA

A Bioengineered Model of Tumor Vessel Interactions in Pancreatic Cancer

$217,819
Esak Lee · Cornell University · R21 · FY2023 · CA

X-ray studies of metalloenzyme regulation and catalysis

$217,686
Massachusetts Institute Of Technology · R01 · FY2002 · GM

Role of Inflammation in the Development and Progression of Pancreatic Cancer

$217,618
Syed Hussain · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Career Development Program

$217,590
Donald J Buchsbaum · University Of Alabama At Birmingham · P50 · FY2010 · CA

NF Center: From Animal Models to Therapeutics

$217,573
David W. Clapp · Ut Southwestern Medical Center · P50 · FY2007 · NS

NF Center: From Animal Models to Therapeutics

$217,573
David A Ingram · Ut Southwestern Medical Center · P50 · FY2007 · NS

Project 3: Immune Checkpoint Inhibition Therapy Enhanced by Integrated Photodynamic Treatment and Image Guidance in Preclinical Models of Pancreatic Cancer

$217,561
Tayyaba Hasan · Massachusetts General Hospital · P01 · FY2024 · CA

Simultaneous attack of epithelial and stromal compartments in pancreatic cancer

$217,546
Philip A Beachy · Stanford University · R21 · FY2012 · CA

Cancer Biology Training Program

$217,505
Jennifer D Black · University Of Nebraska Medical Center · T32 · FY2023 · CA

Experimentally Validated Mathematical Modeling of Oncolytic Virus Infection

$217,503
Wolfgang Michael Korn · University Of California, San Francisco · R01 · FY2006 · CA

Combination Therapy: Targeting Pancreatic Cancer with a ROS Inducer and Gemcitabine

$217,500
Katie Reindl · North Dakota State University · P20 · FY2016 · GM

Therapeutic Antibody Discovery from Pancreatic Cancer B Cell Repertoires

$217,469
David Scott Johnson · Gigagen, Inc. · R43 · FY2014 · CA

Tracking Cellular Migration In Vivo

$217,448
Dario Aa Vignali · St. Jude Children'S Research Hospital · R21 · FY2011 · AI

Activating liver carcinogens in yeast by expressing CYP450 polymorphisms

$217,438
Michael Thomas Fasullo · Ordway Research Institute, Inc. · R21 · FY2008 · ES

Pancreatic Fluid Proteomics in Alcohol Induced Chronic Pancreatitis

$217,425
Darwin Lewis Conwell · Brigham And Women'S Hospital · R21 · FY2011 · DK

Targeting Telomerase in Pancreateic Cancer

$217,425
Derek James Taylor · Case Western Reserve University · R21 · FY2013 · CA

The tumor-suppressive role of ALK4/ACVR1B in pancreatic tumorigenesis

$217,350
Gloria Huei-Ting Su · Columbia University Health Sciences · R21 · FY2008 · CA

Molecular Studies on MUC4 Mucin Gene

$217,319
Surinder Kumar Batra · University Of Nebraska Medical Center · R01 · FY2011 · CA

Southwest Oncology Group

$217,197
Lawrence E Flaherty · Wayne State University · U10 · FY2008 · CA

Targeting the MICAL2 signaling axis in pancreatic cancer

$217,163
Andrew M Lowy · University Of California, San Diego · R21 · FY2023 · CA